
Carmencita Belei
Examiner (ID: 5021, Phone: (571)272-2798 , Office: P/1678 )
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1677, 1641, 1678 |
| Total Applications | 403 |
| Issued Applications | 162 |
| Pending Applications | 10 |
| Abandoned Applications | 231 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16313822
[patent_doc_number] => 20200292560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
[patent_app_type] => utility
[patent_app_number] => 16/845403
[patent_app_country] => US
[patent_app_date] => 2020-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16845403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/845403 | METHODS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | Apr 9, 2020 | Abandoned |
Array
(
[id] => 16178267
[patent_doc_number] => 20200225235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => SENSITIVE DETECTION OF G-PROTEIN COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1 (GASP-1), GASP-1 MICROVESICLES, AND GASP-1 EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/827145
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827145
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827145 | SENSITIVE DETECTION OF G-PROTEIN COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1 (GASP-1), GASP-1 MICROVESICLES, AND GASP-1 EXOSOMES | Mar 22, 2020 | Abandoned |
Array
(
[id] => 16270182
[patent_doc_number] => 20200271669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
[patent_app_type] => utility
[patent_app_number] => 16/806653
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16325
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806653
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806653 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | Mar 1, 2020 | Issued |
Array
(
[id] => 19136460
[patent_doc_number] => 11971406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-30
[patent_title] => Capture and release of particles from liquid samples
[patent_app_type] => utility
[patent_app_number] => 16/777241
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 18
[patent_no_of_words] => 8302
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 340
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16777241
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/777241 | Capture and release of particles from liquid samples | Jan 29, 2020 | Issued |
Array
(
[id] => 16254798
[patent_doc_number] => 20200264172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS USING OLIGONUCLEOTIDES ANTIGENS
[patent_app_type] => utility
[patent_app_number] => 16/751831
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751831
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751831 | Diagnosis of systemic lupus erythematosus using oligonucleotides antigens | Jan 23, 2020 | Issued |
Array
(
[id] => 18342458
[patent_doc_number] => 11639935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => CD8+T-cell subsets as markers for prediction of delayed fracture healing
[patent_app_type] => utility
[patent_app_number] => 16/711480
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 31
[patent_no_of_words] => 11209
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16711480
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/711480 | CD8+T-cell subsets as markers for prediction of delayed fracture healing | Dec 11, 2019 | Issued |
Array
(
[id] => 15592589
[patent_doc_number] => 20200072829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => SYSTEM FOR BIODETECTION APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/668005
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12523
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16668005
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/668005 | System for biodetection applications | Oct 29, 2019 | Issued |
Array
(
[id] => 15529553
[patent_doc_number] => 20200057082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => METHOD OF MEASURING CHOLESTEROL LEVELS BY USING IMMUNOGENIC METHOD
[patent_app_type] => utility
[patent_app_number] => 16/555714
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555714 | METHOD OF MEASURING CHOLESTEROL LEVELS BY USING IMMUNOGENIC METHOD | Aug 28, 2019 | Abandoned |
Array
(
[id] => 15326899
[patent_doc_number] => 20200003779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => METHOD AND DEVICE FOR DETECTING SIGLEC12
[patent_app_type] => utility
[patent_app_number] => 16/552876
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16552876
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/552876 | METHOD AND DEVICE FOR DETECTING SIGLEC12 | Aug 26, 2019 | Abandoned |
Array
(
[id] => 15256505
[patent_doc_number] => 20190376986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => In Vitro Diagnosis Device and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/546493
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16546493
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/546493 | In Vitro Diagnosis Device and Uses Thereof | Aug 20, 2019 | Abandoned |
Array
(
[id] => 15529503
[patent_doc_number] => 20200057057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => Methods and reagents for Toxoplasma infection diagnosis
[patent_app_type] => utility
[patent_app_number] => 16/542865
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16542865
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/542865 | Methods and reagents for Toxoplasma infection diagnosis | Aug 15, 2019 | Pending |
Array
(
[id] => 17643205
[patent_doc_number] => 20220170943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => TEST TO ASSESS LIVER DISEASE SEVERITY
[patent_app_type] => utility
[patent_app_number] => 17/265718
[patent_app_country] => US
[patent_app_date] => 2019-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4869
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17265718
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/265718 | TEST TO ASSESS LIVER DISEASE SEVERITY | Aug 4, 2019 | Pending |
Array
(
[id] => 15296025
[patent_doc_number] => 20190391148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => FLOW CYTOMETRY ASSAY METHODS
[patent_app_type] => utility
[patent_app_number] => 16/513818
[patent_app_country] => US
[patent_app_date] => 2019-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16513818
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/513818 | FLOW CYTOMETRY ASSAY METHODS | Jul 16, 2019 | Abandoned |
Array
(
[id] => 15683693
[patent_doc_number] => 20200096510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => ASSAY
[patent_app_type] => utility
[patent_app_number] => 16/448149
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448149
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448149 | ASSAY | Jun 20, 2019 | Abandoned |
Array
(
[id] => 18129612
[patent_doc_number] => 11555816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes
[patent_app_type] => utility
[patent_app_number] => 16/436700
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 11
[patent_no_of_words] => 5534
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 330
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16436700
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/436700 | Detection of amniotic fluid in vaginal secretions of pregnant women due to premature rupture of fetal membranes | Jun 9, 2019 | Issued |
Array
(
[id] => 19763210
[patent_doc_number] => 12221484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-11
[patent_title] => Anti-NMDA receptor antibodies and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/599399
[patent_app_country] => US
[patent_app_date] => 2019-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 54
[patent_no_of_words] => 25384
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17599399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/599399 | Anti-NMDA receptor antibodies and methods of use | Jun 7, 2019 | Issued |
Array
(
[id] => 14963155
[patent_doc_number] => 20190309055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => Immunoassay for Collagen Type VI
[patent_app_type] => utility
[patent_app_number] => 16/431979
[patent_app_country] => US
[patent_app_date] => 2019-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13595
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/431979 | Immunoassay for collagen type VI | Jun 4, 2019 | Issued |
Array
(
[id] => 15771435
[patent_doc_number] => 20200116735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => Non-Glycosylated suPar Biomarkers and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/424289
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16424289
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/424289 | Non-Glycosylated suPar Biomarkers and Uses Thereof | May 27, 2019 | Abandoned |
Array
(
[id] => 16485347
[patent_doc_number] => 20200378950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => Glycosylation site-specific antibodies and anti-cancer compounds
[patent_app_type] => utility
[patent_app_number] => 16/423060
[patent_app_country] => US
[patent_app_date] => 2019-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423060
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423060 | Glycosylation site-specific antibodies and anti-cancer compounds | May 26, 2019 | Abandoned |
Array
(
[id] => 14810203
[patent_doc_number] => 20190271711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => PROCESSING REAGENT AND USE THEREOF IN ASSAYS FOR DETECTION OF ANALYTES ASSOCIATED WITH A BINDING PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/412218
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/412218 | PROCESSING REAGENT AND USE THEREOF IN ASSAYS FOR DETECTION OF ANALYTES ASSOCIATED WITH A BINDING PROTEIN | May 13, 2019 | Abandoned |